Medifast
MED
219 hedge funds and large institutions have $1.46B invested in Medifast in 2019 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 68 increasing their positions, 82 reducing their positions, and 53 closing their positions.
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
8% more capital invested
Capital invested by funds: $1.36B → $1.46B (+$103M)
4.04% more ownership
Funds ownership: 110.78% → 114.82% (+4%)
8% less funds holding
Funds holding: 239 → 219 (-20)
17% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 82
21% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 53
74% less call options, than puts
Call options by funds: $23.2M | Put options by funds: $89.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
Engaged Capital
Newport Beach,
California
|
+$62.7M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$52.6M |
| 3 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$23.7M |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$17.1M |
| 5 |
1M
13D Management
New York
|
+$14.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$25.1M |
| 2 |
KCM
Kingdon Capital Management
New York
|
-$13.6M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$12.8M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
-$12.7M |
| 5 |
ECP
Elk Creek Partners
Denver,
Colorado
|
-$11.9M |
MED Hedge Fund Activity: Q4 2019 in Review
219 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q4 2019, worth a combined $1.46B — up 7.6% from $1.36B a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of MED and 42 opened new positions — a net loss of 11 holders — while 82 trimmed existing stakes and 68 added.
The largest buyer was Engaged Capital, adding an estimated $62.7M. The largest seller was Hood River Capital Management, exiting entirely with an estimated $25.1M sold.
- 219 institutional investors held Medifast (MED) as of Q4 2019, down from 239 in Q3 2019.
- Funds reported $1.46B of Medifast stock for Q4 2019, up 7.6% quarter-over-quarter.
- 42 funds opened new Medifast positions in Q4 2019 and 53 closed out, a net change of -11 holders.
- The largest Medifast buyer in Q4 2019 was Engaged Capital, an estimated $62.7M added.
- The largest Medifast seller in Q4 2019 was Hood River Capital Management, an estimated $25.1M sold.
Based on aggregated 13F filings for Q4 2019.